WILKES UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1933-01-01
- Employees
- 948
- Market Cap
- -
- Website
- http://www.wilkes.edu
Clinical Trials
3
Active:0
Completed:3
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Assessment of Analgesics and Sedatives in Mechanically Ventilated Patients With COVID-19
Completed
- Conditions
- ARDSCOVID-19Iatrogenic DiseaseWithdrawal Syndrome
- First Posted Date
- 2022-04-20
- Last Posted Date
- 2023-04-26
- Lead Sponsor
- Wilkes University
- Target Recruit Count
- 353
- Registration Number
- NCT05336656
- Locations
- 🇺🇸
Wilkes University, Wilkes-Barre, Pennsylvania, United States
AduLt iatrogEnic withdRawal sTudy in the ICU (ALERT-ICU)
Completed
- Conditions
- Withdrawal SyndromeIatrogenic Disease
- First Posted Date
- 2020-06-09
- Last Posted Date
- 2022-07-29
- Lead Sponsor
- Wilkes University
- Target Recruit Count
- 2437
- Registration Number
- NCT04422808
- Locations
- 🇺🇸
Wilkes University, Wilkes-Barre, Pennsylvania, United States
Improving Medication Adherence Through a Transitional Care Pharmacy Practice Model
Phase 2
Completed
- Conditions
- Pulmonary Disease, Chronic ObstructiveHeart Failure
- First Posted Date
- 2014-01-28
- Last Posted Date
- 2017-05-02
- Lead Sponsor
- Wilkes University
- Target Recruit Count
- 180
- Registration Number
- NCT02047448
- Locations
- 🇺🇸
Moses Taylor Hospital, Scranton, Pennsylvania, United States
News
No news found